Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
2.
Lancet ; 376(9747): 1186-93, 2010 Oct 02.
Artigo em Inglês | MEDLINE | ID: mdl-20709386

RESUMO

Substantial inequalities exist in cancer survival rates across countries. In addition to prevention of new cancers by reduction of risk factors, strategies are needed to close the gap between developed and developing countries in cancer survival and the effects of the disease on human suffering. We challenge the public health community's assumption that cancers will remain untreated in poor countries, and note the analogy to similarly unfounded arguments from more than a decade ago against provision of HIV treatment. In resource-constrained countries without specialised services, experience has shown that much can be done to prevent and treat cancer by deployment of primary and secondary caregivers, use of off-patent drugs, and application of regional and global mechanisms for financing and procurement. Furthermore, several middle-income countries have included cancer treatment in national health insurance coverage with a focus on people living in poverty. These strategies can reduce costs, increase access to health services, and strengthen health systems to meet the challenge of cancer and other diseases. In 2009, we formed the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries, which is composed of leaders from the global health and cancer care communities, and is dedicated to proposal, implementation, and evaluation of strategies to advance this agenda.


Assuntos
Antineoplásicos/economia , Antineoplásicos/uso terapêutico , Países em Desenvolvimento/economia , Política de Saúde , Acessibilidade aos Serviços de Saúde/economia , Neoplasias , Pobreza , Colômbia , Detecção Precoce de Câncer , Saúde Global , Haiti , Acessibilidade aos Serviços de Saúde/normas , Acessibilidade aos Serviços de Saúde/tendências , Necessidades e Demandas de Serviços de Saúde , Vacinas contra Hepatite B/administração & dosagem , Humanos , Incidência , Renda , Cobertura do Seguro , Seguro Saúde , Jordânia , Malaui , Programas de Rastreamento , México , Neoplasias/diagnóstico , Neoplasias/economia , Neoplasias/epidemiologia , Neoplasias/mortalidade , Neoplasias/prevenção & controle , Neoplasias/terapia , Vacinas contra Papillomavirus/administração & dosagem , Saúde Pública , Fatores de Risco , Ruanda , Abandono do Hábito de Fumar , Fatores Socioeconômicos
3.
Nat Rev Cancer ; 20(7): 412, 2020 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-32528184

RESUMO

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA